Showing results (311-320 of 2,483) with videos related to
Sort By:
Pageof 249
Expert Review of Vaccines|October 30, 2009
HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible futureGiulio Tosti, Alessandra di Pietro, Pier Francesco Ferrucci, et al.Expert Review of Vaccines|October 30, 2009
Antituberculous vaccine development: a perspective for the endemic worldIndu Verma, Ajay GroverExpert Review of Vaccines|November 13, 2009
Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Pierre R Smeesters, David J McMillan, Kadaba S Sriprakash, et al.Expert Review of Vaccines|December 1, 2009
Vaccines for enteric diseases: update on recent developmentsChristian SchaettiExpert Review of Vaccines|October 28, 2022
Immune persistence induced by two-dose BBIBP-CorV vaccine with different intervals, and immunogenicity and safety of a homologous booster dose in high-risk occupational populationTian Yao, Xiaohong Zhang, Shengcai Mu, et al.Expert Review of Vaccines|June 9, 2025
Advances in transmission-blocking vaccines against Plasmodium falciparum and Plasmodium vivaxMayumi Tachibana, Eizo Takashima, Motomi Torii, et al.Expert Review of Vaccines|November 12, 2025
An analysis of causality assessed serious and severe adverse events following COVID-19 vaccines administered from January 2021 to September 2022 in IndiaAwnish Kumar Singh, Neneh Feren, Rekha Thapar, et al.Expert Review of Vaccines|November 12, 2025
Safety profile and medium- to long-term protection of the Recombinant Zoster Vaccine (RZV) in a cohort of high-risk patients: real-world data from a General Hospital in Southern Italy, 2021-2025Pasquale Stefanizzi, Lorenza Moscara, Claudia Palmieri, et al.Expert Review of Vaccines|November 13, 2025
Understanding the role of COVID-19 vaccination in all-cause healthcare resource utilisation among adults with long COVID in the UK primary care setting: data from the 2022-2023 respiratory virus seasonKiran K Rai, Hannah Gowman, Cale S Harrison, et al.Expert Review of Vaccines|September 30, 2025
Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2+1 scheduleShahrul Mt-Isa, Justin R Chumbley, Matthew S Kelly, et al.Pageof 249